MS News That Caught My Eye Last Week: Plegridy, Telemedicine, AI for MS, Myelin Repair

MS News That Caught My Eye Last Week: Plegridy, Telemedicine, AI for MS, Myelin Repair

285676

MS News That Caught My Eye Last Week: Plegridy, Telemedicine, AI for MS, Myelin Repair

FDA Approves Plegridy as Intramuscular Injection for Relapsing MS A common patient complaint about Plegridy has been that its subcutaneous injection procedure results in injection site reactions. This new formulation is delivered into the muscle, rather than under the skin. The needle is longer, but Biogen pharmaceuticals thinks the reactions should be fewer. The U.S. Food and Drug Administration (FDA) has approved an intramuscular injection formulation of Plegridy (peginterferon beta-1a) to treat people with relapsing forms…

You must be logged in to read/download the full post.